Zogenix plans offering of 12M shares, as it moves forward on chronic pain product
26 August 2011
Nancy Faigen
Please Login to read the full article.
26 August 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zogenix's long-acting hydrocodone meets chronic pain endpoint, ready for 2012 filing
- Zogenix, Battelle agree to work toward out-licensing needle-free injection platform
- Zogenix, Duract in deal for work on once-monthly risperidone, to contrast with J&J blockbuster
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
